Vascular Covered Stent Market Size, Production, Sales, Average Product Price, Market Share, Import vs Export 

Evolving Therapeutic Needs Reshaping the Vascular Covered Stent Market 

Vascular Covered Stent market size is estimated to be $262 Million in 2025. The market was $248 Million in 2024 and will reach $381 Million by 2032.
The Vascular Covered Stent Market is witnessing a paradigm shift due to increasing demand for advanced vascular intervention technologies. The adoption of vascular covered stents is being accelerated by the rising prevalence of vascular disorders such as peripheral artery disease (PAD), aortic aneurysms, and arteriovenous fistulas. For instance, PAD affects over 200 million individuals globally, and as treatment protocols shift toward minimally invasive options, the demand for covered stents continues to rise.

Growing healthcare infrastructure in emerging economies is also playing a critical role in the market’s expansion. Improved accessibility to vascular surgeries in countries such as India, Brazil, and Indonesia is directly influencing the installation rates of vascular covered stents. Furthermore, enhanced reimbursement frameworks are supporting the integration of such devices across both public and private healthcare systems. 

Technological Innovations Enhancing the Vascular Covered Stent Market 

Innovation remains a cornerstone of the Vascular Covered Stent Market, with manufacturers focusing on next-generation stents that offer superior flexibility, radial strength, and endothelialization. For example, covered stents developed with ePTFE (expanded polytetrafluoroethylene) or polyurethane membranes are showing enhanced biocompatibility and reduced restenosis rates. These material enhancements are supporting procedural efficiency and patient outcomes.

Advancements in drug-eluting stent technologies are also converging with vascular covered stent designs, leading to hybrid products that combine the structural integrity of a covered stent with anti-proliferative drug coatings. These developments are particularly beneficial in complex cases such as recurrent stenosis or post-surgical vascular repair. As a result, the Vascular Covered Stent Market is being propelled by both innovation in design and the expanding scope of application. 

Increasing Incidence of Vascular Disorders Driving the Vascular Covered Stent Market 

The consistent rise in the global geriatric population is directly influencing the growth of the Vascular Covered Stent Market. Individuals aged 65 and above are more susceptible to arterial blockages, aneurysms, and vascular malformations. For instance, abdominal aortic aneurysm (AAA) affects nearly 5% of men over 65, and the increasing frequency of AAA screening is translating into higher intervention rates. 

Additionally, the prevalence of comorbidities such as diabetes and hypertension, which significantly contribute to arterial degeneration, is augmenting demand for vascular covered stents. For example, diabetic patients face a threefold increased risk of developing peripheral vascular complications, further fueling demand for covered stent implantation in lower limb ischemia cases. 

Hospital Infrastructure Development Bolstering the Vascular Covered Stent Market 

Infrastructure modernization in surgical centers and tertiary care hospitals is a critical driver of the Vascular Covered Stent Market. Many high-volume medical centers are expanding their catheterization labs and hybrid operating suites to accommodate a growing number of vascular procedures. This trend is evident across both developed and developing regions. 

For instance, the number of endovascular aneurysm repair (EVAR) procedures has increased significantly in urban hospitals, accounting for over 70% of AAA treatments in certain regions. With increasing procedural volumes, procurement of vascular covered stents is becoming a consistent line item in hospital capital expenditure budgets, supporting long-term market growth. 

Rising Preference for Minimally Invasive Surgery in the Vascular Covered Stent Market 

Minimally invasive procedures are gaining traction across medical specialties, and vascular surgery is no exception. The Vascular Covered Stent Market is benefiting from this shift as covered stents enable efficient, catheter-based interventions with reduced surgical trauma, shorter hospital stays, and lower complication rates. 

Patients and physicians alike are favoring these procedures, particularly in complex vascular conditions such as traumatic arterial injuries or post-angioplasty complications. For example, covered stents are increasingly being used to repair vascular ruptures in trauma patients, where time-sensitive intervention is critical. This surgical pivot is reinforcing the need for flexible, ready-to-use stent solutions in trauma and emergency care settings. 

Application Expansion Supporting Growth in the Vascular Covered Stent Market 

As clinical indications expand, the Vascular Covered Stent Market is finding new avenues for growth. Beyond traditional cardiovascular applications, covered stents are being utilized in renal artery disease, subclavian artery stenosis, and mesenteric ischemia. Such diversification of application is enlarging the addressable market. 

For instance, renal artery stenting is gaining prominence in managing renovascular hypertension, with covered stents showing favorable outcomes in lesion coverage and patency. This widening clinical landscape is encouraging device developers to invest in multipurpose stent systems that meet a variety of anatomical and physiological requirements, thereby boosting overall market penetration. 

Surge in Endovascular Procedures Enhancing the Vascular Covered Stent Market Size 

The Vascular Covered Stent Market Size is expanding in parallel with a global rise in endovascular procedures. In the United States alone, endovascular repair accounts for over 75% of aortic aneurysm treatments annually. Similar patterns are emerging in Europe and Asia-Pacific, where minimally invasive surgeries are becoming the standard of care for vascular intervention. 

This shift is supported by the increased availability of skilled interventional radiologists and vascular surgeons, as well as the incorporation of real-time imaging and navigation technologies. As procedural confidence grows, so does the utilization of advanced vascular covered stents designed for precision deployment and enhanced post-procedural outcomes. 

Reimbursement Structures Strengthening the Vascular Covered Stent Market 

Reimbursement dynamics are becoming increasingly favorable to the Vascular Covered Stent Market, particularly in regions with universal healthcare systems. For instance, revised codes and bundled payment systems in countries like Germany, France, and Japan are incentivizing the use of endovascular technologies, including covered stents, for both elective and emergency procedures. 

Private insurance providers in North America are also recognizing the long-term cost savings associated with reduced readmission rates and shorter inpatient stays, thus encouraging adoption of premium stent systems. This financial backing is instrumental in increasing procedure volumes and facilitating broader acceptance among healthcare providers. 

Competitive Landscape Influencing Strategic Development in the Vascular Covered Stent Market 

The Vascular Covered Stent Market is characterized by active competition among global and regional players. Major medical device firms are engaging in portfolio expansion, strategic collaborations, and M&A activities to strengthen their market position. For example, companies are increasingly acquiring specialized stent manufacturers to enhance their capabilities in vascular intervention. 

This dynamic environment fosters rapid innovation and accelerates product launches tailored to emerging clinical needs. As more players enter the market with differentiated offerings—such as bioresorbable scaffolds or customized stent sizes—the competitive intensity drives both pricing strategies and technological breakthroughs. 

Regulatory Landscape Shaping the Vascular Covered Stent Market 

Regulatory frameworks are evolving to accommodate rapid technological advancements in the Vascular Covered Stent Market. Accelerated approval pathways and fast-track designations are helping innovative products reach the market more quickly, particularly in areas of high unmet clinical need. 

For instance, regulatory bodies are increasingly prioritizing devices with strong real-world evidence of efficacy and safety. This regulatory encouragement is fostering faster commercialization of next-generation vascular covered stents, and at the same time, compelling manufacturers to invest in robust post-marketing surveillance systems. 

Future Outlook for the Vascular Covered Stent Market Size 

The Vascular Covered Stent Market Size is projected to experience substantial growth over the next five to seven years, driven by clinical demand, technological innovation, and broader accessibility. Markets in Asia-Pacific and Latin America, in particular, are expected to see accelerated growth due to favorable demographics, rising income levels, and increased public health spending. 

Looking forward, the development of smart stents—incorporating sensors and wireless communication for real-time monitoring—could redefine market dynamics. These advancements, coupled with evolving clinical guidelines promoting early intervention, position the Vascular Covered Stent Market for sustained momentum and transformative impact on vascular healthcare. 

“Track Country-wise Vascular Covered Stent Production and Demand through our Database”

• • Vascular Covered Stent sales volume database for 28+ countries worldwide

 

North America Dominates Global Vascular Covered Stent Market Due to High Disease Burden 

The Vascular Covered Stent Market in North America continues to maintain its dominance, driven by a combination of high vascular disease prevalence, advanced healthcare infrastructure, and strong reimbursement mechanisms. For instance, the United States records over 200,000 new cases of abdominal aortic aneurysm (AAA) annually, with endovascular repair procedures growing at over 5% CAGR in recent years. The region’s healthcare systems are quick to adopt newer covered stent technologies, particularly for treating complex lesions and traumatic vascular injuries. 

Furthermore, the United States remains the hub for product innovation, where leading players frequently launch next-generation vascular covered stents tailored for both peripheral and central vascular applications. Canada is also showing steady uptake, especially in urban tertiary care centers where hybrid vascular surgeries are increasingly performed. Datavagyanik notes that North America alone accounts for over 35% of the global Vascular Covered Stent Market, largely due to rapid procedural adoption and consistent product approvals. 

Europe Demonstrates Steady Growth in Vascular Covered Stent Market with Focus on Peripheral Applications 

Europe is emerging as a strong secondary market in the global Vascular Covered Stent Market, supported by a robust clinical research ecosystem and a rise in peripheral artery disease (PAD) cases. For instance, the prevalence of PAD in Europe is estimated to be over 40 million, with aging populations in countries like Germany, France, and Italy contributing to procedural growth. The market is also influenced by favorable policy measures, such as funding for minimally invasive vascular procedures in national healthcare systems. 

Vascular surgeons in Europe are increasingly opting for covered stents in iliac and femoral artery interventions, where arterial complications are more frequent. Datavagyanik highlights that Europe’s contribution to the global Vascular Covered Stent Market is expected to increase at a stable 4% to 6% annual rate, supported by ongoing clinical trials and local manufacturing expansions. 

Asia-Pacific Witnessing Accelerated Growth in Vascular Covered Stent Market 

Asia-Pacific is rapidly becoming the most dynamic region in the Vascular Covered Stent Market, led by improving healthcare infrastructure and a surge in vascular disorder diagnosis rates. For example, in China and India, rising cases of diabetes and hypertension are driving a significant increase in peripheral vascular diseases. The patient population eligible for covered stent procedures is growing exponentially, creating fertile ground for market expansion. 

In countries like South Korea and Japan, where healthcare systems are highly technology-driven, covered stents are being deployed for complex aortic arch interventions and renal artery treatments. Additionally, the establishment of regional manufacturing hubs is enhancing affordability and product accessibility. Datavagyanik observes that the Vascular Covered Stent Market in Asia-Pacific is projected to grow at a CAGR exceeding 9% over the next five years. 

Latin America Emerging as a Developing Vascular Covered Stent Market 

The Vascular Covered Stent Market in Latin America is gradually maturing, with Brazil and Mexico leading the regional landscape. For instance, Brazil has seen a 30% rise in endovascular procedures over the past five years, attributed to public health system reforms and increased procedural training. Covered stents are being adopted in trauma centers, particularly in major metropolitan areas, for addressing vascular injuries in accident cases. 

While the region faces challenges such as inconsistent product availability and limited reimbursement in rural zones, Datavagyanik notes that strategic investments in localized vascular covered stent manufacturing will be key to unlocking further growth potential in this emerging market. 

Middle East and Africa Displaying Moderate Yet Promising Growth in Vascular Covered Stent Market 

The Vascular Covered Stent Market in the Middle East and Africa is still in its nascent stages but holds considerable promise due to the rapid modernization of healthcare systems in countries such as Saudi Arabia, UAE, and South Africa. For instance, large-scale government investments in cardiac and vascular centers have created an environment conducive to adopting covered stents for both elective and emergency interventions. 

Growing collaborations between international manufacturers and local healthcare providers are helping improve device penetration. Datavagyanik indicates that the region’s demand will steadily rise as interventional radiology and vascular surgery programs expand their training capabilities and procedural volumes. 

Diversified Product Segmentation Structuring the Vascular Covered Stent Market 

The Vascular Covered Stent Market is segmented into various product types based on material composition, application area, and delivery mechanism. Material-wise, ePTFE and polyurethane-coated stents dominate the landscape due to their enhanced sealing properties and reduced restenosis risks. For instance, ePTFE-covered stents are widely used in dialysis access interventions where long-term patency is essential. 

From an application standpoint, the market includes aortic, peripheral, renal, subclavian, and carotid stenting. Among these, peripheral vascular interventions hold the largest market share due to the sheer volume of PAD cases globally. The rapid expansion of therapeutic indications is driving further segmentation, such as venous stents, which are gaining traction in chronic venous insufficiency management. 

Datavagyanik also highlights segmentation based on end-user categories—hospitals, ambulatory surgical centers, and specialty clinics—with hospitals accounting for the bulk of covered stent installations due to their comprehensive procedural capabilities. 

Technological Maturity Driving Vascular Covered Stent Manufacturing 

Vascular Covered Stent Manufacturing has become increasingly sophisticated, integrating advanced material science, robotic precision, and automated quality control. Leading manufacturers are adopting laser cutting and electrospinning techniques to ensure optimal mesh consistency and membrane integration. For example, nanotechnology is being used in surface modification to reduce thrombogenicity and improve endothelial growth. 

Regional manufacturing units are rising, especially in Asia-Pacific, to minimize import costs and shorten supply chains. Datavagyanik notes that countries like China and India are building domestic manufacturing capabilities not just to serve local markets but to supply emerging economies across Africa and Southeast Asia. This shift in vascular covered stent manufacturing is also reducing overall device cost, thereby promoting broader accessibility. 

Price Trend Analysis Reflects Competitive and Cost-Driven Market Dynamics 

The Vascular Covered Stent Market exhibits diverse pricing dynamics, influenced by material selection, manufacturing origin, regulatory classification, and brand reputation. For instance, drug-eluting or high-performance hybrid covered stents are priced significantly higher than basic ePTFE variants. However, as vascular covered stent manufacturing scales up in lower-cost geographies, price gaps are narrowing. 

Datavagyanik observes that average stent prices have declined by 8% to 10% in certain markets over the past three years, driven by competition and the availability of local alternatives. At the same time, price-sensitive buyers—such as public healthcare providers—are negotiating volume-based pricing models to manage cost while maintaining clinical outcomes. 

In developed markets, reimbursement-linked pricing strategies are becoming common, with bundled payments and outcome-based pricing pushing manufacturers to offer stents that demonstrate superior long-term value. As price transparency and digital procurement platforms improve, competitive dynamics will continue to pressure high-margin segments of the Vascular Covered Stent Market. 

Local Sourcing and Customization Rising in Vascular Covered Stent Manufacturing 

Customization and regional adaptation are emerging as focal points in vascular covered stent manufacturing. Manufacturers are increasingly offering stents in multiple lengths and diameters tailored to diverse anatomical profiles. For example, stents designed for Asian patient populations often require different flexibility and sizing metrics compared to those intended for Western markets. 

Additionally, collaborations with interventional specialists are influencing stent development cycles. Manufacturers are partnering with surgeons to design custom solutions for rare vascular anomalies and pediatric applications. Datavagyanik highlights that these innovations not only improve patient outcomes but also enhance brand loyalty and regional adoption. 

As vascular covered stent manufacturing becomes more agile and responsive, local sourcing strategies will ensure faster delivery timelines and reduced inventory costs. This operational flexibility is becoming a crucial differentiator in a market that demands precision, reliability, and rapid clinical deployment. 

“Vascular Covered Stent Manufacturing Database”

• • • Vascular Covered Stent top manufacturers market share for 28+ manufacturers
    • Top 8 manufacturers and top 18 manufacturers of Vascular Covered Stent in North America, Europe, Asia Pacific
    • Vascular Covered Stent sales dashboard, Vascular Covered Stent sales data in excel format

Dominance of Key Players in the Vascular Covered Stent Market 

The Vascular Covered Stent Market is led by a select group of global medical device manufacturers who have invested heavily in research, clinical development, and market expansion. These companies control a significant portion of the global market through innovative vascular technologies, strong distribution networks, and comprehensive vascular portfolios.

Among the leaders, Becton, Dickinson and Company (BD), W. L. Gore & Associates, Medtronic, Boston Scientific, and Cook Medical maintain prominent positions. Other growing contenders include Terumo Corporation and MicroPort Scientific Corporation. These manufacturers are strategically positioning themselves across various vascular applications such as peripheral artery disease, arteriovenous access, trauma-related vascular repair, and aortic interventions. 

Becton, Dickinson and Company Leading with Dual Product Strategy 

BD has become a major force in the Vascular Covered Stent Market due to the commercial success of two flagship products—Covera™ Vascular Covered Stent and LifeStream™ Vascular Covered Stent. The Covera™ is widely used in maintaining arteriovenous access in dialysis patients, while the LifeStream™ is designed for the treatment of iliac artery lesions. Together, these products account for a substantial market share in both hospital-based and ambulatory settings.

BD’s continued investment in production scalability and design optimization has strengthened its presence globally, particularly in North America and Europe, where procedure volumes are consistently high. L. Gore & Associates Holding a Dominant Share in Peripheral Segment
L. Gore & Associates has long been recognized for its Viabahn® Endoprosthesis, a self-expanding, heparin-bonded stent graft widely used for superficial femoral artery occlusions and complex peripheral vascular cases. The Viabahn® line has become a gold standard in many vascular centers due to its long-term patency and flexibility, especially in anatomically challenging lesions.

With Viabahn® leading the segment, W. L. Gore commands a large share of the peripheral Vascular Covered Stent Market, benefiting from consistent demand across developed healthcare systems. 

Medtronic’s Integrated Approach to the Vascular Covered Stent Market 

While Medtronic is better known for its drug-eluting and bare-metal stents, it has strategically expanded its portfolio to include covered stents for specific indications such as aortic coarctation, renal artery repair, and post-trauma vascular injury. Its approach integrates imaging, navigation, and delivery technologies to offer comprehensive procedural support. 

Medtronic’s wide-reaching hospital partnerships and clinical programs have enabled it to maintain competitive share, particularly in hybrid vascular procedures that involve both open and endovascular techniques. 

Terumo and MicroPort Accelerating Market Penetration in Asia-Pacific 

Terumo Corporation has leveraged its strong cardiovascular device ecosystem to enter the Vascular Covered Stent Market with products focused on lower limb ischemia and renal artery interventions. The company’s growing presence in Japan, China, and Southeast Asia is being supported by its commitment to regional manufacturing and clinical training programs. 

MicroPort Scientific Corporation is gaining ground through competitive pricing and market-specific product customization. Its growing distribution across emerging economies is improving access to vascular covered stents in high-growth, price-sensitive regions, enhancing its position as a serious challenger in the global market. 

Cook Medical and Boston Scientific Maintaining Competitive Edge 

Cook Medical’s contributions to the Vascular Covered Stent Market include its Zilver® PTX® product line. While this product is primarily a drug-eluting stent, it targets peripheral artery disease patients similar to covered stents, often used where restenosis risk is high. Its clinical adoption has helped Cook maintain share in the peripheral vascular intervention space. 

Boston Scientific, meanwhile, continues to expand its vascular product portfolio and develop customized covered stents for specific arterial territories. Its investments in innovation and physician partnerships support its relevance in both acute and chronic vascular care pathways. 

Manufacturer Market Share in the Vascular Covered Stent Market 

The global Vascular Covered Stent Market is distributed among the top five players as follows: 

• BD: Approx. 22%–25% share, supported by strong product lines and hospital-based dominance. 

• W. L. Gore & Associates: Holds 20%–23%, primarily in the peripheral vascular segment. 

• Medtronic: Estimated 15%–18% share, with broad clinical reach and integrated solutions. 

• Terumo and MicroPort combined: 10%–12%, with strong regional traction in Asia-Pacific. 

• Cook Medical and Boston Scientific: 10%–12%, driven by niche offerings and hybrid technologies. 

The remaining share is split among regional players and niche manufacturers who focus on specific indications or custom stent production. Market consolidation is limited, allowing space for innovation-driven new entrants. 

Recent Industry Developments in the Vascular Covered Stent Market 

March 2025: BD announced the global rollout of a next-generation version of its Covera™ stent, designed with enhanced conformability for tortuous vascular segments. This update is aimed at improving long-term patency in dialysis patients. 

February 2025: W. L. Gore launched an extended-length Viabahn® stent graft, enabling treatment of longer lesions in superficial femoral arteries with fewer device deployments, reducing procedural time. 

January 2025: MicroPort completed the establishment of a new manufacturing unit in Southeast Asia to cater to the rising demand in emerging markets. This strategic expansion aims to reduce cost and lead times for hospitals. 

December 2024: Terumo introduced a modular delivery system compatible with its new line of covered stents, improving deployment precision in narrow and curved arterial pathways. 

November 2024: Boston Scientific signed a development agreement with a European research institute to co-develop bioresorbable covered stents, targeting low-risk peripheral artery disease cases. 

 

“Vascular Covered Stent Production Data and Vascular Covered Stent Production Trend”

• • • Vascular Covered Stent sales database for historical years, 10 years historical data
    • Vascular Covered Stent sales data and forecast for next 7 years